← SynDRA
UCB-1184197
SynDRA canonical compound SYN0039521 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ITGA4 | ITGB7 |
|---|
| Mechanism of action | integrin antagonist |
|---|
| Indication | multiple sclerosis |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- ITGA4 INHIBITOR
- Integrin alpha-4 inhibitor
- integrin antagonist
- Modulator
Cross-references
Synonyms
- CDP323
- Zaurategrast ethyl ester
- CDP-323
- Zaurategrast
- (S)-3-(4-((2,7-Naphthyridin-1-yl)amino)phenyl)-2-((2-bromo-3-oxospiro[3.5]non-1-en-1-yl)amino)propanoic acid
- UNII-06A0IC74I3
- 06A0IC74I3
- C26H25BrN4O3
- Zaurategrast [INN]
- SCHEMBL2976322
- CTK8C0588
- DTXSID90196547
- MolPort-023-332-826
- KS-00001DY0
- ANW-64932
- 6274AB
- ZINC100041912
- AKOS016005046
- CS-0322
- N-(2-Bromo-3-oxospiro[3.5]non-1-en-1-yl)-4-(2,7-naphthyridin-1-ylamino)-L-phenylalanine
- NCGC00378753-01
- 9A54BAZ0YA
- RefChem:192868
- DTXCID70119037
- UNII-9A54BAZ0YA
- CDP323;UCB1184197
- MFCD18207040
- C28H29BrN4O3
- orb1708185
- SCHEMBL3833843
- SCHEMBL29373839
- CS-M0212
- AKOS037650075
- T13388L
- CS-14216
- HY-75385
- DB-236670
Look up UCB-1184197 in the interactive SynDRA portal →